CT98014 is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate in the synthesis of biologically active compounds, particularly those targeting specific enzymes or receptors involved in disease pathways. Researchers employ CT98014 in the design and optimization of small molecule inhibitors, which are crucial for developing therapies for conditions such as cancer, inflammation, and metabolic disorders. Its structural properties make it a versatile building block for creating compounds with enhanced potency, selectivity, and pharmacokinetic profiles. Additionally, CT98014 is often used in high-throughput screening assays to identify potential drug candidates, contributing to the discovery of novel therapeutic agents.